Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos A M Fraga

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Current Medicinal Chemistry|February 14, 2006
Medicinal chemistry of N-acylhydrazones: new lead-compounds of analgesic, antiinflammatory and antithrombotic drugsCarlos A M Fraga, Eliezer J Barreiro
Current Drug Targets|February 23, 2018
NF-κB-IKKβ Pathway as a Target for Drug Development: Realities, Challenges and PerspectivesRosana H C N Freitas, Carlos A M Fraga
Mini Reviews in Medicinal Chemistry|April 29, 2016
Beyond the Selective Inhibition of Histone Deacetylase 6Daniel A Rodrigues, Sreekanth Thota, Carlos A M Fraga
Medicinal Chemistry (Shariqah (United Arab Emirates))|February 27, 2016
Understanding the Structural Basis of ALDH-2 Inhibition by Molecular DockingThayssa T S C Ferreira, Carlos A M Fraga
Mini Reviews in Medicinal Chemistry|November 30, 2007
Privileged structures: a useful concept for the rational design of new lead drug candidatesCarolina D Duarte, Eliezer J Barreiro, Carlos A M Fraga
Pharmaceuticals (Basel, Switzerland)|May 9, 2019
Duvelisib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Phosphoinositide 3-KinasesDaniel A Rodrigues, Fernanda S Sagrillo, Carlos A M Fraga
Chemmedchem|October 13, 2020
Multitarget Inhibition of Histone Deacetylase (HDAC) and Phosphatidylinositol-3-kinase (PI3K): Current and Future ProspectsDaniel A Rodrigues, Pedro S M Pinheiro, Carlos A M Fraga
Drug Discovery Today|February 17, 2016
Filtering promiscuous compounds in early drug discovery: is it a good idea?Mario R Senger, Carlos A M Fraga, Rafael F Dantas, et al.
Molecules (Basel, Switzerland)|November 9, 2011
MAOS and medicinal chemistry: some important examples from the last yearsNailton M Nascimento-Júnior, Arthur E Kümmerle, Eliezer J Barreiro, et al.
Plos One|May 27, 2016
Discovery of Novel Orally Active Tetrahydro-Naphthyl-N-Acylhydrazones with In Vivo Anti-TNF-α Effect and Remarkable Anti-Inflammatory PropertiesNatália M Cordeiro, Rosana H C N Freitas, Carlos A M Fraga, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Current Medicinal Chemistry|February 14, 2006
Medicinal chemistry of N-acylhydrazones: new lead-compounds of analgesic, antiinflammatory and antithrombotic drugsCarlos A M Fraga, Eliezer J Barreiro
Current Drug Targets|February 23, 2018
NF-κB-IKKβ Pathway as a Target for Drug Development: Realities, Challenges and PerspectivesRosana H C N Freitas, Carlos A M Fraga
Mini Reviews in Medicinal Chemistry|April 29, 2016
Beyond the Selective Inhibition of Histone Deacetylase 6Daniel A Rodrigues, Sreekanth Thota, Carlos A M Fraga
Medicinal Chemistry (Shariqah (United Arab Emirates))|February 27, 2016
Understanding the Structural Basis of ALDH-2 Inhibition by Molecular DockingThayssa T S C Ferreira, Carlos A M Fraga
Mini Reviews in Medicinal Chemistry|November 30, 2007
Privileged structures: a useful concept for the rational design of new lead drug candidatesCarolina D Duarte, Eliezer J Barreiro, Carlos A M Fraga
Pharmaceuticals (Basel, Switzerland)|May 9, 2019
Duvelisib: A 2018 Novel FDA-Approved Small Molecule Inhibiting Phosphoinositide 3-KinasesDaniel A Rodrigues, Fernanda S Sagrillo, Carlos A M Fraga
Chemmedchem|October 13, 2020
Multitarget Inhibition of Histone Deacetylase (HDAC) and Phosphatidylinositol-3-kinase (PI3K): Current and Future ProspectsDaniel A Rodrigues, Pedro S M Pinheiro, Carlos A M Fraga
Drug Discovery Today|February 17, 2016
Filtering promiscuous compounds in early drug discovery: is it a good idea?Mario R Senger, Carlos A M Fraga, Rafael F Dantas, et al.
Molecules (Basel, Switzerland)|November 9, 2011
MAOS and medicinal chemistry: some important examples from the last yearsNailton M Nascimento-Júnior, Arthur E Kümmerle, Eliezer J Barreiro, et al.
Plos One|May 27, 2016
Discovery of Novel Orally Active Tetrahydro-Naphthyl-N-Acylhydrazones with In Vivo Anti-TNF-α Effect and Remarkable Anti-Inflammatory PropertiesNatália M Cordeiro, Rosana H C N Freitas, Carlos A M Fraga, et al.
Pageof 10